baber/WOPTO huggingface dataset:
Patent NZ-517885-A (NZ)
Title: Fence mesh forming machine, knot box and method
Inventor: RICHARD KENNETH SIDNEY
IPC: B65B13/28
Filed: 2002-03-20
Abstract: A knot box for forming a knot at the intersection between a line wire and a stay wire in a knotted fence mesh forming machine. The knot box includes: a staple former arranged to move towards the line wire-stay wire intersection from one side at each operation of the knot box, cut a length of knot wire extending at an angle across the line wire-stay wire intersection, and bend the cut length of knot wire around the line wire-stay wire intersection; and a final former arranged to move towards the line wire-stay wire intersection from the side opposite the staple former and bend and wrap the ends of the cut length of knot wire about the line wire or stay wire to form the finished knot wire about the line wire-stay wire intersection. Also disclosed is a knotted fence mesh forming machine including a machine bed with a plurality of side by side knot boxes, and a method of forming a knot at an intersection between a line wire and a stay wire.
Patent NZ-519365-A (NZ)
Title: Antigenic composition comprising a recombinant protein and antibodies for porphyromonas gingivalis infection
Inventor: REYNOLDS ERIC CHARLES
IPC: A61K39/395
Filed: 2000-12-21
Abstract: An antigenic composition comprises of at least one recombinant protein having a molecular weight less than or equal to 44kDa.  The recombinant protein contains at least one epitope, which is reactive with an antibody.  The antibody is reactive with a polypeptide having the sequence set out in SEQ. ID NO. 3 or SEQ. ID. NO. 5.  Preferably, the recombinant protein has a sequence selected from the group consisting of SEQ. ID. NO. 3, residues 1-184, 1-290, 65-184, 65-290, 65-419, 192-290, 192-419, 147-419, SEQ. ID. NO 5 and SEQ. ID. NO 6.  A recombinant prokaryotic or eukaryotic cell comprises an introduced DNA sequence selected from the group consisting of SEQ. ID. NO 1, nucleotides 1-1257 of SEQ. ID. NO. 1, nucleotides 1-552 of SEQ. ID. NO 1, nucleotides 1-870 of SEQ. ID. NO. 1, nucleotides 193-552 of SEQ. ID. NO 1, nucleotides 193-870 of SEQ. ID. NO. 1, nucleotides 193 - 1257 of SEQ. ID. NO 1, nucleotides 574-870 of SEQ. ID. NO. 1 nucleotides 574-1257 of SEQ. ID. NO 1, nucleotides 439-1257 of SEQ. ID. NO. 1, SEQ. ID. NO. 7, SEQ. ID. NO. 1, SEQ. ID. NO. 7, SEQ. ID. NO. 8.  The recombinant cell is capable of expressing a recombinant protein as described earlier.  The antigenic and antibody may be used in preventing, reducing the incidence or severity of Porphyomonas gingivalis in a subject.
Patent NZ-519632-A (NZ)
Title: Dosage forms that include a barrier layer containing a material that allows the layer to remain intact during laser formation of the orifice(s)
Inventor: GEERKE JOHAN H
IPC: A61K9/00
Filed: 2000-12-11
Abstract: A dosage form for delivery of a therapeutic agent to a subject is described. The dosage form contains: (a) an outer wall defining an interior compartment; (b) within the interior compartment, a therapeutic agent; (c) at least one exit orifice formed by laser ablation of the outer wall for release of the agent therethrough, and (d) a barrier layer disposed between the outer wall and the interior compartment in at least a region corresponding to the exit orifice. The barrier layer comprises a material that allows the barrier layer to remain intact during laser-formation of the at least one exit orifice in the outer wall. Also disclosed is a method for controlling the depth of laser ablation of a dosage form during laser formation of an exit orifice in an outer wall of the dosage form. The figure depicts dosage form (10), which contains an outer wall (12) that defines an interior compartment (14), visible in the cut-away of the figure. Outer wall (1) is composed of a material that is permeable to the passage of fluid, but is substantially impermeable to the passage of drug or therapeutic agent, e.g., a semipermeable material. Materials suitable for formation of the outer wall include synthetic and naturally occurring semipermeable polymer materials. In one embodiment, the polymer is a thermoplastic polymer. When a thermoplastic polymer is selected as the material for outer wall (12_, outer wall (12) is essentially non-toxic and maintains its physical and chemical integrity during the delivery life of therapeutic agent from the device. Internal compartment (14) of dosage form (10) includes a therapeutic agent (15) intended to be released from the dosage form (10) into the environment of use. The therapeutic agent can be either soluble, insoluble, or combinations thereof in the external fluid imbibed into the dosage form (10).
Patent NZ-520119-A (NZ)
Title: Retention of oral appliances for sleep related disorders
Inventor: L ESTRANGE PETER
IPC: A61F5/56
Filed: 2000-12-14
Abstract: An oral appliance for the medical treatment of specific sleep related disorders, i.e., snoring and obstructive sleep apnoea, which ahs a number of sections for each jaw component which can be separated for ease of insertion and removal by patients. The separable components can be moved along an inherent guidance system and safely secured in the closed position by a bilateral locking mechanism. By virtue of the difference in paths of location of the main and the separate sections of each component, effective resistance to dislodgement of the appliance is obtained and maintained. This constitutes the claimed significant improvement in appliance retention.
Patent NZ-521485-A (NZ)
Title: Sample preparation apparatus with automated conveying linear reciprocation stirring and rotary stirring
Inventor: CALIS FRANK
IPC: G01N33/04
Filed: 2001-10-31
Abstract: The apparatus has control means to receive inputs and activate conveying, linear reciprocation and rotary stirring.
Patent NZ-521562-A (NZ)
Title: Pre-filled syringe
Inventor: HENDERSON MALCOLM JOHN
IPC: A61M5/31
Filed: 2001-03-28
Abstract: A pre-filled syringe comprising a glass barrel (1), a sealing member (5) fitted in a medical liquid discharge port (11) of the barrel (1), a tip member (2) mounted around the sealing member (5) on the medical liquid discharge port (11) of the barrel (1), a closing member (4), a cap member (3), and a holding member (6); the sealing member (5) having a through-hole (51) formed in the axial direction; the tip member (2) including a skirt (24) provided with an engagement pawl (25) on the inner wall of a lower end thereof, a top wall (23), a needle mounting portion (21), and a medical liquid deriving portion (22), and being provided with a medical liquid passage (28); the closing member (4) being inserted into the medical liquid passage (28) and the through-hole (51) to close the through- hole (51) and so prevent oxygen contamination and deterioration of the medical liquid.
Patent NZ-522821-A (NZ)
Title: Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory: pre- and post-natal administration
Inventor: SPONG CATHERINE Y
IPC: A61K38/08
Filed: 2001-05-31
Abstract: A composition for improving learning and/or memory in a subject, the composition comprising an Activity Dependent Neurotrophic Factor (ADNF) polypeptide in an amount sufficient to improve postnatal learning and/or memory of the subject, wherein the ADNF polypeptide is a mixture of: a) an ADNF I polypeptide comprising an active core site having the amino acid sequence:  Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala b) an ADNF III polypeptide comprising an active core site having the amino acid sequence:  Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln
Patent NZ-525658-A (NZ)
Title: Boxes tagged with custom printed seam tape
Inventor: FAUST MICHAEL C
IPC: C09J7/20
Filed: 1999-03-31
Abstract: Adhesive tape is applied to a box and information is printed on the tape either before or after the tape is applied, to form a label for the box. The tape has a non paper backing layer and must be of a suitable opacity to provide a suitable so-called scan rating for, especially, bar code information printed on the tape. (62) Divided out of 512195
Patent NZ-533558-A (NZ)
Title: Benzimidazole derivatives and their use as GnRH antagonists
Inventor: POITOUT LYDIE
IPC: A61K31/4184
Filed: 2002-12-20
Abstract: Benzimidazole derivatives of general formula (I) are disclosed. These compounds have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. Compounds of formula (I) are useful in the preparation of a medicament for: the treatment, in women, of a condition selected from the list consisting of endometriosis, fibroma, polycystic ovary syndrome, cancer of the breast, cancer of the ovary, cancer of the endometrium and gonadotropic hypophyseal desensitization during medically-assisted procreation protocols the treatment, in men, of benign prostatic hyperplasia and prostate cancer the treatment of precocious male or femal puberty.
Patent NZ-541270-A (NZ)
Title: Cyclic urea derivatives, preparation method thereof and pharmaceutical use of the same as kinase inhibitors
Inventor: PATEK MARCEL
IPC: A61P3/00
Filed: 2004-01-28
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are protein kinase inhibitors useful in the treatment of cancers such as solid tumours.
Patent NZ-547562-A (NZ)
Title: Wireless communication system for an enclosed environment and a lift system having the same
Inventor: BASSIRI MASOUD
IPC: H04B7/26
Filed: 2003-11-28
Abstract: A wireless communication system for providing a radio frequency (RF) link between an enclosed environment that is at least substantially shielded from RF signals, and the outside of the enclosed environment is disclosed. The wireless communication system comprises at least one gateway antenna arranged at an entrance point of the enclosed environment so as to radiate downlink RF signals into and receive uplink RF signals from, the enclosed environment, respectively; at least one auxiliary repeater arranged within the enclosed environment; a donor antenna coupled to the auxiliary repeater; and a server antenna coupled to the auxiliary repeater. The auxiliary repeater relays the downlink and uplink RF signals using the donor antenna and the server antenna.
Patent NZ-552419-A (NZ)
Title: Bottle mount for use with a dispenser or an applicator
Inventor: LAUCHLAN GARETH NIGEL
Filed: 2006-12-22
Abstract: A mount (200) for a bottle includes a base (2) and a plurality of spaced apart upstanding arms (6). The arms (6) have an inwardly directed neck engagement portion (12). The mount includes a bottle shroud (9) positioned about the arms (6) and rotatable relative thereto. The shroud (9) has a plurality of inwardly facing cam portions (7), each of which engages with a respective arm (6) to move the arm (6) inward when the shroud (9) is rotated, thereby clamping the neck engagement portions (12) about a neck (10) of a bottle (9)positioned in a space between the base (2) and arms (6). Further rotation of the shroud (9)draws the neck (10) of the bottle (11) downwardly towards the base (2) to a sealing position 10 and a secured mounting.
Patent NZ-554617-A (NZ)
Title: Antibody compositions useful for the treatment and diagnosis of immune related diseases
Inventor: CLARK HILARY
IPC: A61K38/16
Filed: 2004-11-12
Abstract: Disclosed is an antibody which specifically binds to PRO87288 (SEQ ID NO: 2) and blocks or mimics HVEM interaction with PRO87299. Further disclosed are methods and uses of said antibody
Patent NZ-555595-A (NZ)
Title: Orchid sleeving apparatus
Inventor: FLOYD IAN RONALD
IPC: A01G5/00
Filed: 2007-05-31
Abstract: Apparatus suitable for or for assisting the sleeving or bagging of cut flowers such as, for example, orchids. The apparatus includes a slide, a mount for the sleeve or bag at or adjacent one end of the slide, and a drive operable to move a cut flower stem first, by acting on the stem and/or any apparatus (e.g. vial) engaged to the stem (whether on a mat or not), from the slide into the sleeve or bag attached to the mount so that the bloom of the flower is in the sleeve or bag. The mount is or includes at least one of an expandable lip arrangement and/or expandable iris arrangement.
Patent NZ-555691-A (NZ)
Title: Improvements in or relating to infant attire with labyrinth openings for safety belt type restraint
Inventor: NILSSON AMELIA ANNE BRISTED
IPC: A41B13/00
Filed: 2007-06-06
Abstract: The disclosure is for a modular infant clothing assembly. The assembly has a main garment, with at least one panel defining a sack that includes an anterior and posterior side into which at least the torso of an infant can be located. At the junction of the anterior and posterior sides, there is first aperture for a head of the infant to protrude through, and a pair of second apertures though which arms of the infant can protrude through. A portion of at least one side is openable to allow the infant to be received inside the main garment. Lapped or lapping labyrinth openings are provided through anterior and posterior sides so that a child safety restraint can be passed through the main garment via the openings. Preferably there are also attachments for the main garment selected from any one of more of, a sleeve or sleeves, a mitten or glove for a sleeve or sleeves, a main garment extension, and a piece of headwear.
Patent NZ-566640-A (NZ)
Title: Red lettuce of the species Lactuca sativa having red leaves throughout the head including the heart
Inventor: MOOR CORNELIS MARINUS
IPC: A01H5/12
Filed: 2006-09-20
Abstract: Disclosed is a head-forming lettuce plant of the species Lactuca sativa having red leaves throughout the head, including the heart, having the genetic constitution of the seeds as deposited on 18 July 2005 with the NCIMB under accession numbers NCIMB 41337, NCIMB 41338 and NCIMB 41339.
Patent NZ-569401-A (NZ)
Title: VIP fragments and methods of use
Inventor: DUGGAN KAREN ANNETTE
IPC: A61K38/08
Filed: 2006-12-08
Abstract: Disclosed is a peptide of the following sequence: Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-X, wherein X is absent or selected from the group consisting of -Leu-Arg-Lys-Gln, -Leu-Arg- Lys-Gln-Met-Ala-Val-Lys, -Leu-Arg-Lys-Gln-Met-Ala-Val-Lys- Lys-Tyr-Leu-Asn and -Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn or conservative substitutions thereof. Also disclosed is the use of a peptide for the manufacture of a medicament for the therapeutic or prophylactic treatment of myocardial fibro s is and/or hypertension in a subject with myocardial fibrosis.
Patent NZ-578556-A (NZ)
Title: Antiviral nucleoside analogs
Inventor: BABU YARLAGADDA S
IPC: A61P35/00
Filed: 2008-01-11
Abstract: Disclosed is the use of a compound of formula (I) in the manufacture of a medicament for treating viral infections where in the substituents are as disclosed in the specification and examples of compounds of formula (I) are: (2S,3R,4R,5R)-2-(4-Aminopyrrolo[1,2-j][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol; (2S,3R,4R,5R)-2-(4-(Dimethylamino)pyrrolo[1,2-j][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol; and (2S,3R,4R,5R)-2-(4-Amino-5-bromopyrrolo[1,2-j][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol. Examples of the viral infection are from the group consisting of: hepatitis B, hepatitis C, human immunodeficiency virus, Polio, Coxsackie A and B, Rhino, Echo, small pox, Ebola, and West Nile virus.
Patent NZ-578687-A (NZ)
Title: Electric fence retractable wire gate with guide support and constant tension
Inventor: SEARLE ALAN KEITH
IPC: E06B11/02
Filed: 2010-07-27
Abstract: A retractable electrified gate assembly (1) for a fence-line having a gateway therethrough including a gate (3) is disclosed. The retractable electrified gate assembly comprises a length of resilient material (LRM) connected at one end to a first side of the fence-line (8) and connected at the other end to a length of conducting material (LCM). The LCM is configured to at least span the width from the first side (5) of the gateway (2) to a second side (10) of said gateway (2) to obstruct the gateway; and the LCM includes a fence closure connector on at least one end thereof configured to fasten the LCM to the second side of the gateway. The first side of the gateway includes a guide support (11) which controls the retraction of the LCM and LRM by guiding the LCM and LRM during retraction thereof from the second side of the gateway to the first side of the gateway; and holds the connector off the ground when the LCM and LRM are in a retracted position on the first side of the gateway by preventing a portion of the LRM, LCM and/or fence closure connector passing therethrough, thereby maintaining the LRM and LCM under sufficient tension to support the weight of the fence closure connector. The LRM is substantially parallel with the length of fence-line to which it is attached; and the connection between the LRM and the LCM is configured to apply at least a portion of any longitudinal tension with the LRM to the LCM. A kit of parts for an electrified gate assembly as described above includes a length of conducting material (LCM) connected to a length of resilient material (LRM); a fence closure connector in the form of an insulated handle to protect the gate user from being shocked by the LCM when fastening the LCM to the second side of the gateway, or freeing the LCM therefrom;   a guide-support configured to control the retraction of the LCM and LRM; and hold the insulated handle off the ground when the LCM and LRM are in a retracted position; an attachment device for fixing one end of the LRM capable of allowing the LRM to be maintained under tension and an electrical attachment device for connecting the LCM at the fixed end thereof, or alternatively the attachment device to a live conductor of an associated electric fence. The connection of the LRM and the LCM is such as to be capable of in use allowing the LRM to be maintained under tension even when the LCM is in the fully retracted position.
Patent NZ-579814-A (NZ)
Title: A portable banner
Inventor: ROGERS JASON PAUL
IPC: G09F17/00
Filed: 2010-09-21
Abstract: A self-supporting banner assembly 5000 comprises one sheet of material 5001 which will form the banner, a plurality of support locators 5003 and a plurality of telescopic strut members. In use the sheet material 5001 has at least one vertical fold creating sections on either side of the fold. Support locators 5003 are attached to the corners of each section and are used to retain diagonally disposed telescopic struts in each section to the sheet material 5001.
Patent NZ-580284-A (NZ)
Title: Method of butt fusing the bell shaped ends of two PVC conduit sections together
Inventor: BECKER WILLIAM F
IPC: B29C65/18
Filed: 2008-04-14
Abstract: Disclosed is a method for fusing a first conduit section (116) to a second conduit section (118). Each section is manufactured from a polyvinyl chloride (PVC) composition and includes a linear portion (102) and a bell portion (106). The bell portions have a first section (108) having an inside diameter that is substantially the same as the linear portion of the conduit section, a second section (112) extending from the first section and having an inside diameter that gradually increases, and a third section (122) extending from the second section to the end (110) of the conduit section and having an inside diameter that is substantially constant. The inside diameter of the third section is greater than the inside diameter of the first section. The method includes; heating and melting at least a portion of the end of the first conduit section and the end of the second conduit section; and butt fusing the first conduit section and the second conduit section by engaging the end of the first bell portion of the first conduit section with the end of the bell portion of the second conduit section such that an inner bead is formed between the end of the bell portion of the first conduit section and the end of the bell portion of the second conduit section, thereby forming a conduit having a butt fused joint area (120).
Patent NZ-589445-A (NZ)
Title: Rasagiline for parkinson's disease modification
Inventor: LEVY RUTH
IPC: A01N33/02
Filed: 2009-06-12
Abstract: Disclosed herein is the use of rasagiline, or a pharmaceutically acceptable salt of rasagiline at a dose of 1 mg of rasagiline per day in the manufacture of a medicament to reduce the rate of progression of Parkinson's disease in an early stage Parkinson's disease patient.
Patent NZ-589709-A (NZ)
Title: High speed rollup door with rollable door leaf with a dampening profile fixed to each end of a top lammels
Inventor: FREDE FRIEDHELM
IPC: E06B9/17
Filed: 2008-06-06
Abstract: An industrial rollup door to selectively cover a doorway fitted with side rails 20 and a cross piece spanning the doorway width proximate to the top of the doorway, comprises a door leaf comprising a plurality of elongated rigid lamellae 11, each lamella 11 having a left end portion, a right end portion, a top portion, a bottom portion, an inner surface and an outer surface, at least one flexible lifting belt 6 on each end portion of the lamellae 11, end pieces 5 fitted to the end portions of each lamella 11 to engage the lifting belt 6 at an intermediate portion, a continuous, flexible dampening profile strip 4 fixed to each end portion of a top lamella and positioned on the outer surface of the end portions of a plurality of lamellae, and a rotatable shaft 1. The rotatable shaft 1 is fitted with a spiral disc profile 2 including a dampening profile attached to the outer circumference, the spiral disc profile adapted to accept the lamellae in successive layers as the shaft 1 rotates in a first direction, and to release the lamellae as the shaft 1 rotates in a second direction.
Patent NZ-592331-A (NZ)
Title: Lactose and cellulose-based tableting aid
Inventor: SCHWARZ EUGEN
IPC: A61K9/20
Filed: 2009-09-21
Abstract: Disclosed herein is process for producing a granulate comprising the steps of: i) suspending or/and at least partially dissolving lactose and optionally at least one cellulose derivative in at least one liquid and ii) atomizing the solution or suspension obtained in i) in an environment above room temperature onto cellulose derivative particles and optionally lactose particles during which the liquid is at least partially removed.
Patent NZ-596232-A (NZ)
Title: Lid for a container created using a thermomoulding process and having retention means formed separately to the molding
Inventor: LONG STEVEN
IPC: B29B11/00
Filed: 2011-11-04
Abstract: 596232 Disclosed is a lid for engagement to a compatible open top container to fully overlie the container yet to engage under a profile feature, or profile features, of the container on its outside. The lid comprising: a central closed region (3), a downwardly directed wall (5) forming a peripheral skirt region, and localised retention features (2). The engagement is reliant on the localised retention features of the lid, the localised retention (2) features having been introduced by a mechanical process into a moulded preform of the lid in regions when stretch exposed for the modification.
Patent NZ-596783-A (NZ)
Title: Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
Inventor: VENKATARAMANI CHANDRASEKAR
IPC: C07C275/26
Filed: 2010-06-07
Abstract: The present invention provides a compound of general Formula (I) having histone deacctylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound
Patent NZ-597756-A (NZ)
Title: Method for purifying recombinant adamts13 and other proteins and compositions thereof
Inventor: FIEDLER CHRISTIAN
IPC: C12N9/64
Filed: 2010-08-02
Abstract: 597756 Disclosed are methods for purifying recombinant A Disintegrin-Iike and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises contacting the sample with hydroxyapatite under conditions that allow the ADMATS13 to flow through the faction and the non-ADAMTS13 proteins to bind to the hydroxyapatite.